As Part D Drug Prices are Rising are Profits Falling?

The House Oversight and Government Reform Committee says the prices paid by consumers for the ten most prescribed drugs in the Part D program rose an average of 6.8% since December. At the same time, the committee says wholesale prices have risen just 3%.The committee also says that rebates from the drug companies to the Part D players total 4.6% of total drug costs--down from 5.2% last year.